Oregon Health & Science University
Portland, Oregon, 97239, United States
NCT Number: NCT01647464
Flank pain has been reported with ultrasound (US) contrast agents. The purpose of this study is to determine whether there is retention of ultrasound contrast agents in the renal microcirculation, which has been described in mice.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Portland, Oregon, 97239, United States
In this study patients undergoing clinically indicated contrast echocardiography will have renal ultrasound performed 10 minutes after completion of contrast infusion to determine the presence and location of renal retention of lipid microbubbles.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 min
Video intensity units in the kidney 10 min after completion of a clinically indicated contrast echocardiography study.
Oregon Health and Science University
Other
Study of Whether There is Renal Retention of Lipid Microbubble Ultrasound Contrast Agents
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.